FDA — authorised 5 April 1961
- Application: NDA012254
- Marketing authorisation holder: SCHERING
- Local brand name: TINDAL
- Indication: TABLET — ORAL
- Status: approved
FDA authorised Tindal on 5 April 1961
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 5 April 1961; FDA has authorised it.
SCHERING holds the US marketing authorisation.